Loading...

SPRY ARS PHARMACEUTICALS INC Management Changes 8-K Filing

RS P

SPRY

ARS PHARMACEUTICALS INC

(SPRY)

2026 8-K

Financial Results Announced

Leadership Change

Financial Results Revealed

Financial Update

Credit Agreement Signed

Patent Challenge Notice

Quarterly Earnings Report

Financial Statements

Investor Meetings

Financial Results

Financial Update

Financial Results

Collaboration Agreement

Supply Agreement

Manufacturing Agreement

Financial Results Announcement

Corporate Presentation Upda...

Presentation Update

Financial Results Announcement

Financial Results Announcement

Financial Update

Financial Results Announcement

Presentation Update

Financial Results Announcement

Annual Meeting of Stockholders

Regulation FD Disclosure

Financial Results Announcement

FDA Briefing Documents for ...

Financial Results Announcement

Presentation Update

Termination Agreement with ...

Financial Update

External Links:

ARS Pharmaceuticals, Inc. appointed Donn Casale as President, effective June 1, 2026, with an annual salary of $575,000 and eligibility for a bonus up to 45%. This appointment was reported on May 12, 2026, and is significant for the company.

AI Assistant

ARS PHARMACEUTICALS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.